2019

Brierley, D. I., Harman, J. R., Giallourou, N., Leishman, E., Roashan, A. E., Mellows, B. A. D., Bradshaw, H. B., Swann, J. R., Patel, K., Whalley, B. J. and Williams, C. M. ORCID: https://orcid.org/0000-0003-4452-671X (2019) Chemotherapy-induced cachexia dysregulates hypothalamic and systemic lipoamines and is attenuated by cannabigerol. Journal of Cachexia, Sarcopenia and Muscle, 10 (4). pp. 844-859. ISSN 2190-6009 doi: https://doi.org/10.1002/jcsm.12426

2017

Brierley, D. I., Samuels, J., Duncan, M., Whalley, B. J. and Williams, C. M. ORCID: https://orcid.org/0000-0003-4452-671X (2017) A cannabigerol-rich Cannabis sativa extract, devoid of ∆9-tetrahydrocannabinol, elicits hyperphagia in rats. Behavioural Pharmacology, 28 (4). pp. 280-284. ISSN 0955-8810 doi: https://doi.org/10.1097/FBP.0000000000000285

2016

Brierley, D. I., Samuels, J., Duncan, M., Whalley, B. J. and Williams, C. M. ORCID: https://orcid.org/0000-0003-4452-671X (2016) Cannabigerol is a novel, well-tolerated appetite stimulant in pre-satiated rats. Psychopharmacology, 233 (19-20). pp. 3603-3613. ISSN 0033-3158 doi: https://doi.org/10.1007/s00213-016-4397-4

Brierley, D., Samuels, J., Duncan, M., Whalley, B. and Williams, C. ORCID: https://orcid.org/0000-0003-4452-671X (2016) Neuromotor tolerability and behavioural characterisation of cannabidiolic acid, a phytocannabinoid with therapeutic potential for anticipatory nausea. Psychopharmacology, 233 (2). pp. 243-254. ISSN 1432-2072 doi: https://doi.org/10.1007/s00213-015-4100-1